FFA
IPHA

Farther Finance Advisors’s Innate Pharma IPHA Stock Holding History

Farther Finance Advisors’s Portfolio IPHA Stock Details IPHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38 Buy
21
+11
+110% +$18 ﹤0.01% 5868
2026
Q1 		$14 Hold
10
– – ﹤0.01% 5675
2025
Q4 		$18 Hold
10
– – ﹤0.01% 5399
2025
Q3 		$19 Buy
+10
New +$20 ﹤0.01% 4909

Other funds holding IPHA

GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Farther Finance Advisors's IPHA Position: Q2 2026 in Review

Farther Finance Advisors increased its Innate Pharma (IPHA) stake by 110% in Q2 2026, buying an estimated $18 and bringing the position to 21 shares worth $38. The position accounts for ﹤0.01% of the portfolio, ranked #5868.

Farther Finance Advisors first reported a position in IPHA in Q3 2025 and has held it in 4 quarters since. 2 funds tracked by Wall St. Rank hold IPHA as of Q2 2026.

  • Farther Finance Advisors held 21 shares of Innate Pharma worth $38 as of Q2 2026.
  • Farther Finance Advisors bought 11 Innate Pharma shares in Q2 2026, an estimated $18.
  • Innate Pharma made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5868 holding.
  • Farther Finance Advisors first reported a position in Innate Pharma in Q3 2025 and has held it in 4 quarters since.
  • 2 funds tracked by Wall St. Rank held Innate Pharma as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.